BridgeMD
Tests treatment safety and results for Sarcopenia
Official title The Effectiveness and Safety of Combined Research on Uremic Sarcopenia
ClinicalTrials.gov ID: NCT07724587
What this study is testing
- What it's testing
- Objective: To investigate the clinical efficacy and safety of mindfulness meditation during dialysis combined with pre-dialysis progressive resistance training (PRT) for sarcopenia in patients undergoing maintenance hemodialysis (MHD). Methods: In the randomized controlled trial, 76 MHD patients with sarcopenia were divided into three groups: control group (CG), sports group (SG), and intervention group (IG).
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 80
You may be able to join if
- Meet the updated Asian diagnostic criteria for sarcopenia
- Stable vital signs and general physical condition
- Willing and able to cooperate with supervised exercise training
- Regular hemodialysis 3 times per week for at least 3 months
You likely can't join if
- Acute cardiovascular or cerebrovascular events within the previous 3 months
- Cognitive dysfunction affecting study cooperation and exercise completion
- Severe osteoarticular or limb movement disorders preventing standardized exercise training
- Active systemic infection
The study team makes the final eligibility decision.
Where it's taking place
- Ningbo, China
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 80 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Ningbo, China. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.